Sarah Stewart (cancer researcher) at the age of 39. Stewart returned to the NIH in 1951, joining the National Cancer Institute (NCI), and eventually becoming medical director. Stewart developed an interest in researching viral links to cancer in light of the pioneering research of Jonas Salk in developing a vaccine for the virus which caused polio. Stewart developed an interest in researching viral links to cancer in light of the pioneering research of Jonas Salk in developing a vaccine for the virus which caused polio. Stewart is credited with discovering the Polyomavirus in 1953. She and research partner, Dr. Bernice E. Eddy, were successful
SAV001 a feasible option for an HIV vaccine. Indeed, Jonas Salk developed a therapeutic HIV vaccine in 1987, called Remune now being developed by Immune Response BioPharma, Inc., is based on the killed whole virus approach. Remune vaccine has completed over 25 clinical studies to date and showed a robust mechanism of action restoring white blood cell counts in CD4 & CD8 T cells by reducing viral load and increasing immunity. Also, a group of researchers and professionals in the field of HIV strongly advocates that the killed HIV approach must be taken to fight back the global HIV and AIDS